Spray drying is a preferred process for manufacturing amorphous solid dispersions to provide oral bioavailability enhancement for low solubility small molecules, which represent approximately 70% of the new chemical entity pipeline. A robust, efficient scale-up process that ensures critical-to-quality attributes (CQAs) are maintained is crucial to the commercial viability of these molecules.  This webinar focuses on manufacturing aspects of amorphous spray-dried dispersions (SDDs) to enable successful scale-up and optimization of the process. An overview of spray drying and typical scale-up challenges is presented along with methodologies that enable rapid scale-up that is right the first time from clinical to commercial scale.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center